Cargando…

112P Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents

Detalles Bibliográficos
Autores principales:	Muñoz, F. Longo, Salgado, A. Cortés, Domingo, J.J. Serrano, Casado, J.L., Vallejo, A., Serrano, C. Saavedra, Pérez, J. Chamorro, Rodríguez, D.I. Rosero, Velasco, H., Martin, A., Soria, A., Garcia, M.E. Olmedo, Rueda, A. Gomez, Lage, Y., Gordoa, T. Alonso, Cerrillo, J. Molina, Borau, P. Gajate, Martínez del Frade, Í., Lopez, P. Garrido, Carrato-Mena, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662599/ http://dx.doi.org/10.1016/j.annonc.2021.10.130

Ejemplares similares

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
por: Albarrán, Víctor, et al.
Publicado: (2022)

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments
por: Cortés, Alfonso, et al.
Publicado: (2022)

Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
por: Grande, Enrique, et al.
Publicado: (2017)

Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
por: Molina-Cerrillo, Javier, et al.
Publicado: (2020)

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
por: Molina-Cerrillo, Javier, et al.
Publicado: (2022)

Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
por: Vida Navas, Elena María, et al.
Publicado: (2021)

Novel Tyrosine Kinase Targets in Urothelial Carcinoma
por: Torres-Jiménez, Javier, et al.
Publicado: (2021)

The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide
por: Serrano Domingo, Juan José, et al.
Publicado: (2021)

Targeting Tyrosine kinases in Renal Cell Carcinoma: “New Bullets against Old Guys”
por: Alonso-Gordoa, Teresa, et al.
Publicado: (2019)

Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms
por: Pozas, Javier, et al.
Publicado: (2019)

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors
por: Saavedra, Cristina, et al.
Publicado: (2023)

The new element 112
por: Hofmann, S, et al.
Publicado: (1996)

Chemical identification and properties of element 112
por: Yakushev, A B, et al.
Publicado: (2002)

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy
por: San Román Gil, María, et al.
Publicado: (2020)

Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report
por: Pozas, Javier, et al.
Publicado: (2022)

1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
por: Serrano Domingo, J.J., et al.
Publicado: (2020)

Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Alfranca, Yolanda Lage, et al.
Publicado: (2022)

112 dinámicas /
por: Londoño S.J., Alejandro
Publicado: (1995)

Emerging use of everolimus in the treatment of neuroendocrine tumors
por: Gajate, Pablo, et al.
Publicado: (2017)

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)

Search of the decay of the heaviest isotopes of element 112
por: Oganessian, Yu T, et al.
Publicado: (1998)

BRAF Mutated Colorectal Cancer: New Treatment Approaches
por: Molina-Cerrillo, Javier, et al.
Publicado: (2020)

Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies
por: Sotelo, M., et al.
Publicado: (2020)

Tyrosine Kinase Receptors in Oncology
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2020)

112 Developing Outpatient Registry to Capture Data Post Hospitalization
por: Schmoker, Bethany A, et al.
Publicado: (2022)

Evidence that duplications of 22q11.2 protect against schizophrenia
por: Rees, E, et al.
Publicado: (2014)

Integration of genetic, transcriptomic, and clinical data provides insight into 16p11.2 and 22q11.2 CNV genes
por: Vysotskiy, Mikhail, et al.
Publicado: (2021)

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
por: Dickerman, Barbra A., et al.
Publicado: (2021)

Multi-fragment production for reactions of $^{112}Sn + ^{112}Sn$ and $^{124}Sn + ^{124}Sn$ at E/A=40 MeV
por: Kunde, G J, et al.
Publicado: (1996)

Deformed intruder band in $^{112}$Te: first evidence for rotational behaviour in the tellurium isotopes
por: Paul, E S, et al.
Publicado: (1994)

Neuroanatomical Phenotypes in a Mouse Model of the 22q11.2 Microdeletion
por: Ellegood, J., et al.
Publicado: (2013)

Combinations of genes at the 16p11.2 and 22q11.2 CNVs contribute to neurobehavioral traits
por: Vysotskiy, Mikhail, et al.
Publicado: (2023)

Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents
por: Breznik, Jessica A., et al.
Publicado: (2021)

P1273: INVESTIGATING THE ONCOGENIC POTENTIAL OF STAT5BN642H IN NK CELLS
por: Klein, K., et al.
Publicado: (2022)

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
por: Kingwell, Bronwyn A., et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Otologic and audiologic findings in 22q11.2 deletion syndrome
por: Verheij, E., et al.
Publicado: (2016)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Common and specific impairments in attention functioning in girls with chromosome 22q11.2 deletion, fragile X or Turner syndromes
por: Quintero, Andrea I, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ft0sferpi90k4h99ig8tgju7p2